/ CompletedNot Applicable TEMPO (iMOvifa) Glaucoma Screening
* The primary objective of this study is to evaluate the diagnostic accuracy of the TEMPO (iMOvifa) visual field perimeter screening test by measuring the sensitivity in a population of eyes with glaucoma and the specificity in a population of normal eyes and to measure repeatability of the screening test.
* The secondary objective of this study is to gather and analyze ancillary data to confirm the diagnosis or absence of glaucoma.
100 Clinical Results associated with Cape Fear Eye Institute Llc.
0 Patents (Medical) associated with Cape Fear Eye Institute Llc.
100 Deals associated with Cape Fear Eye Institute Llc.
100 Translational Medicine associated with Cape Fear Eye Institute Llc.